- Home
- FARM vs TVRD Comparison
FARM vs TVRD Comparison
Compare FARM & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FARM | TVRD |
|---|---|---|
| Founded | 1912 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4M | 37.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FARM | TVRD |
|---|---|---|
| Price | $1.55 | $4.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $2.75 | ★ $51.67 |
| AVG Volume (30 Days) | 76.0K | ★ 149.5K |
| Earning Date | 02-05-2026 | 02-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $338,816,000.00 | N/A |
| Revenue This Year | $4.36 | N/A |
| Revenue Next Year | $3.31 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.34 | $3.74 |
| 52 Week High | $3.29 | $43.65 |
Technical Indicators
Market Signals| Indicator | FARM | TVRD |
|---|---|---|
| Relative Strength Index (RSI) | 56.68 | 49.71 |
| Support Level | $1.42 | $3.87 |
| Resistance Level | $1.60 | $4.75 |
| Average True Range (ATR) | 0.06 | 0.34 |
| MACD | 0.01 | 0.15 |
| Stochastic Oscillator | 91.11 | 70.29 |
Price Performance
Historical ComparisonAbout FARM Farmer Brothers Company
Farmer Bros Co is engaged in manufacturing, wholesaling, and distributing coffee, tea, and culinary products to food-service establishments and retailers in the United States. The company's customers include restaurants, hotels, offices, casinos, convenience stores, healthcare facilities, and other food-service providers. The company's product categories include roast and ground coffee, frozen liquid coffee, flavored and unflavored iced and hot teas, culinary products, spices, and other beverages, such as cappuccino, cocoa, granitas, and ready-to-drink iced coffee.
About TVRD Tvardi Therapeutics Inc.
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.